[Therapy with cerebral anti-hypoxidotics].
D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D002534:Hypoxia, Brain / Q000188:drug therapy*; D002504:Meclofenoxate / Q000627:therapeutic use; D010889:Piracetam / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014717:Vertigo / Q000188:drug therapy; D014749:Vincamine / Q000627:therapeutic use; D014971:Xanthinol Niacinate / Q000627:therapeutic use
D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D014971:Xanthinol Niacinate; D014749:Vincamine; D002504:Meclofenoxate; D010889:Piracetam
Zur Therapie mit zerebralen Antihypoxidotika.